129 related articles for article (PubMed ID: 1563214)
1. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
Stoschitzky K; Lindner W; Egginger G; Brunner F; Obermayer-Pietsch B; Passath A; Klein W
Clin Pharmacol Ther; 1992 Apr; 51(4):445-53. PubMed ID: 1563214
[TBL] [Abstract][Full Text] [Related]
2. Stereoselective hemodynamic effects of (R)-and (S)-propranolol in man.
Stoschitzky K; Lindner W; Rath M; Leitner C; Uray G; Zernig G; Moshammer T; Klein W
Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):474-8. PubMed ID: 2739756
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of propranolol enantiomers in healthy male volunteers.
Paradiso-Hardy FL; Walker SE; Bowles SK
Int J Clin Pharmacol Ther; 1998 Jul; 36(7):370-5. PubMed ID: 9707351
[TBL] [Abstract][Full Text] [Related]
4. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
Stoschitzky K; Kahr S; Donnerer J; Schumacher M; Luha O; Maier R; Klein W; Lindner W
Clin Pharmacol Ther; 1995 May; 57(5):543-51. PubMed ID: 7768077
[TBL] [Abstract][Full Text] [Related]
5. Direct enantioselective determination of (R)- and (S)-propranolol in human plasma. Application to pharmacokinetic studies.
Egginger G; Lindner W; Brunner G; Stoschitzky K
J Pharm Biomed Anal; 1994 Dec; 12(12):1537-45. PubMed ID: 7696378
[TBL] [Abstract][Full Text] [Related]
6. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
Stoschitzky K; Lindner W
Wien Med Wochenschr; 1990 Apr; 140(6-7):156-62. PubMed ID: 1971978
[TBL] [Abstract][Full Text] [Related]
7. Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies.
Stoschitzky K; Klein W; Stark G; Stark U; Zernig G; Graziadei I; Lindner W
Clin Pharmacol Ther; 1990 Jun; 47(6):740-6. PubMed ID: 2162749
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R,S)-propranolol.
Lindner W; Rath M; Stoschitzky K; Semmelrock HJ
Chirality; 1989; 1(1):10-3. PubMed ID: 2642031
[TBL] [Abstract][Full Text] [Related]
9. Synergistic adverse hemodynamic interaction between oral verapamil and propranolol.
Carruthers SG; Freeman DJ; Bailey DG
Clin Pharmacol Ther; 1989 Oct; 46(4):469-77. PubMed ID: 2791449
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
Stoschitzky K; Egginger G; Zernig G; Klein W; Lindner W
Chirality; 1993; 5(1):15-9. PubMed ID: 8383518
[TBL] [Abstract][Full Text] [Related]
11. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
[TBL] [Abstract][Full Text] [Related]
12. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
Bode W; Toet AE; Stolker AA; van Ginkel LA; Groen K; Wemer J; de Wildt DJ
Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
[TBL] [Abstract][Full Text] [Related]
13. The effect of dosage release formulations on the pharmacokinetics of propranolol stereoisomers in humans.
Bleske BE; Welage LS; Rose S; Amidon GL; Shea MJ
J Clin Pharmacol; 1995 Apr; 35(4):374-8. PubMed ID: 7650226
[TBL] [Abstract][Full Text] [Related]
14. Age and beta-adrenergic receptor sensitivity to S(-)- and R,S(+/-)-propranolol in humans.
Colangelo PM; Blouin RA; Steinmetz JE; McNamara PJ; DeMaria AN; Wedlund PJ
Clin Pharmacol Ther; 1992 May; 51(5):549-54. PubMed ID: 1316824
[TBL] [Abstract][Full Text] [Related]
15. Stereoselective hydrolysis of O-isovaleryl propranolol and its influence on the clearance of propranolol after oral administration.
Shameem M; Imai T; Yoshigae Y; Sparreboom A; Otagiri M
J Pharm Sci; 1994 Dec; 83(12):1754-7. PubMed ID: 7891307
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol.
Levine MA; Ogilvie RI; Leenen FH
Clin Pharmacol Ther; 1988 Jan; 43(1):39-48. PubMed ID: 2826066
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
[TBL] [Abstract][Full Text] [Related]
18. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
[TBL] [Abstract][Full Text] [Related]
19. Effects of diltiazem on the disposition and metabolism of the enantiomers of propranolol in the dog during multiple oral dosing.
Lankford SM; Maskasame C; Bai SA
Drug Metab Dispos; 1994; 22(5):776-87. PubMed ID: 7835231
[TBL] [Abstract][Full Text] [Related]
20. Exercise increases plasma concentrations of (R)- and (S)-propranolol.
Stoschitzky K; Schumacher M; Stark G; Dimai HP; Stauber R; Stoschitzky P; Krejs GJ; Klein W; Lindner W
Eur J Clin Pharmacol; 1996; 50(4):339-42. PubMed ID: 8803530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
